{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T22:28:16Z","timestamp":1781044096861,"version":"3.54.1"},"reference-count":101,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","jcardioanesthesia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1053\/j.jvca.2024.12.022","type":"journal-article","created":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T00:42:10Z","timestamp":1734568930000},"page":"653-665","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["The Efficacy and Safety of Angiotensin II for Treatment of Vasoplegia in Critically Ill Patients: A Systematic Review"],"prefix":"10.1053","volume":"39","author":[{"given":"Yuki","family":"Kotani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Lezzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlotta Pia","family":"Murru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish K","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Zarbock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rinaldo","family":"Bellomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8594-5980","authenticated-orcid":false,"given":"Giovanni","family":"Landoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.jvca.2024.12.022_bib0001","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1161\/hy1201.101214","article-title":"History about the discovery of the renin-angiotensin system","volume":"38","author":"Basso","year":"2001","journal-title":"Hypertension"},{"key":"10.1053\/j.jvca.2024.12.022_bib0002","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1172\/JCI101265","article-title":"The hemodynamic effects of angiotonin in normal man","volume":"20","author":"Bradley","year":"1941","journal-title":"J Clin Invest"},{"key":"10.1053\/j.jvca.2024.12.022_bib0003","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1097\/CCM.0000000000002441","article-title":"Clinical experience with IV angiotensin II administration: A systematic review of safety","volume":"45","author":"Busse","year":"2017","journal-title":"Crit Care Med"},{"key":"10.1053\/j.jvca.2024.12.022_bib0004","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1056\/NEJMoa1704154","article-title":"Angiotensin II for the treatment of vasodilatory shock","volume":"377","author":"Khanna","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2024.12.022_bib0005","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/anae.15802","article-title":"A double-blind randomised feasibility trial of angiotensin-2 in cardiac surgery","volume":"77","author":"Coulson","year":"2022","journal-title":"Anaesthesia"},{"key":"10.1053\/j.jvca.2024.12.022_bib0006","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1213\/ANE.0000000000006839","article-title":"A pilot study of renin-guided angiotensin-II infusion to reduce kidney stress after cardiac surgery","volume":"139","author":"Sadjadi","year":"2024","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2024.12.022_bib0007","doi-asserted-by":"crossref","first-page":"e14754","DOI":"10.1111\/ctr.14754","article-title":"Effects of angiotensin II in the management of perioperative hypotension in kidney transplant recipients","volume":"36","author":"Andrews","year":"2022","journal-title":"Clin Transplant"},{"key":"10.1053\/j.jvca.2024.12.022_bib0008","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1002\/jmv.27592","article-title":"Angiotensin II infusion in COVID-19: An international, multicenter, registry-based study","volume":"94","author":"Serpa Neto","year":"2022","journal-title":"J Med Virol"},{"key":"10.1053\/j.jvca.2024.12.022_bib0009","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1007\/s00134-003-1986-6","article-title":"Hyperreninemic hypoaldosteronism: A possible etiological factor of septic shock-induced acute renal failure","volume":"29","author":"du Cheyron","year":"2003","journal-title":"Intensive Care Med"},{"key":"10.1053\/j.jvca.2024.12.022_bib0010","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1001\/archinte.1983.00350040125016","article-title":"Association of hypotension with hyperreninemic hypoaldosteronism in the critically ill patient","volume":"143","author":"Davenport","year":"1983","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.jvca.2024.12.022_bib0011","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1213\/ANE.0000000000006682","article-title":"Renin as a prognostic marker in intensive care and perioperative settings: A scoping review","volume":"138","author":"Kotani","year":"2024","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2024.12.022_bib0012","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13054-020-2733-x","article-title":"Angiotensin I and angiotensin II concentrations and their ratio in catecholamine-resistant vasodilatory shock","volume":"24","author":"Bellomo","year":"2020","journal-title":"Crit Care"},{"key":"10.1053\/j.jvca.2024.12.022_bib0013","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13613-024-01304-3","article-title":"Renin in critically ill patients","volume":"14","author":"Kotani","year":"2024","journal-title":"Ann Intensive Care"},{"key":"10.1053\/j.jvca.2024.12.022_bib0014","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.kint.2020.07.047","article-title":"Impaired angiotensin II type 1 receptor signaling contributes to sepsis-induced acute kidney injury","volume":"99","author":"Leisman","year":"2021","journal-title":"Kidney Int"},{"key":"10.1053\/j.jvca.2024.12.022_bib0015","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1097\/CCM.0000000000002797","article-title":"Urinary oxygenation as a surrogate measure of medullary oxygenation during angiotensin II therapy in septic acute kidney injury","volume":"46","author":"Lankadeva","year":"2018","journal-title":"Crit Care Med"},{"key":"10.1053\/j.jvca.2024.12.022_bib0016","doi-asserted-by":"crossref","first-page":"R190","DOI":"10.1186\/cc8185","article-title":"Angiotensin II in experimental hyperdynamic sepsis","volume":"13","author":"Wan","year":"2009","journal-title":"Crit Care"},{"key":"10.1053\/j.jvca.2024.12.022_bib0017","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/S0022-5223(19)41947-8","article-title":"Response of pulmonary vascular segments to angiotensin and norepinephrine","volume":"63","author":"Baum","year":"1972","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1053\/j.jvca.2024.12.022_bib0018","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0014-2999(95)00343-J","article-title":"Comparison of responses of canine pulmonary artery and vein to angiotensin II, bradykinin and vasopressin","volume":"282","author":"Sai","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"10.1053\/j.jvca.2024.12.022_bib0019","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: An updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1053\/j.jvca.2024.12.022_bib0020","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: A revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1053\/j.jvca.2024.12.022_bib0021","unstructured":"Wells GA, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Available at: https:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp. 2021. Accessed November 14, 2024."},{"key":"10.1053\/j.jvca.2024.12.022_bib0022","doi-asserted-by":"crossref","first-page":"e0230","DOI":"10.1097\/CCE.0000000000000230","article-title":"Physiologic response to angiotensin II treatment for Coronavirus disease 2019-induced vasodilatory shock: A retrospective matched cohort study","volume":"2","author":"Leisman","year":"2020","journal-title":"Crit Care Explor"},{"key":"10.1053\/j.jvca.2024.12.022_bib0023","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1177\/0885066619872720","article-title":"A retrospective review of angiotensin II use in adult patients with refractory distributive shock","volume":"35","author":"Wong","year":"2020","journal-title":"J Intensive Care Med"},{"key":"10.1053\/j.jvca.2024.12.022_bib0024","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.chest.2020.08.2074","article-title":"Angiotensin II infusion for shock: A multicenter study of postmarketing use","volume":"159","author":"Wieruszewski","year":"2021","journal-title":"Chest"},{"key":"10.1053\/j.jvca.2024.12.022_bib0025","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1213\/ANE.0000000000005953","article-title":"The association between angiotensin II and renin kinetics in patients after cardiac surgery","volume":"134","author":"Meersch","year":"2022","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2024.12.022_bib0026","doi-asserted-by":"crossref","first-page":"e0623","DOI":"10.1097\/CCE.0000000000000623","article-title":"Effectiveness of angiotensin II for catecholamine refractory septic or distributive shock on mortality: A propensity score weighted analysis of real-world experience in the medical ICU","volume":"4","author":"Quan","year":"2022","journal-title":"Crit Care Explor"},{"key":"10.1053\/j.jvca.2024.12.022_bib0027","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1177\/0885066620972943","article-title":"A multicenter observational cohort study of angiotensin II in shock","volume":"37","author":"Smith","year":"2022","journal-title":"J Intensive Care Med"},{"key":"10.1053\/j.jvca.2024.12.022_bib0028","doi-asserted-by":"crossref","first-page":"e0687","DOI":"10.1097\/CCE.0000000000000687","article-title":"Protocol compliance guiding angiotensin II use in post cardiovascular surgery vasoplegia","volume":"4","author":"Ten Lohuis","year":"2022","journal-title":"Crit Care Explor"},{"key":"10.1053\/j.jvca.2024.12.022_bib0029","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1177\/08850666221145864","article-title":"Angiotensin II for vasodilatory hypotension in patients requiring mechanical circulatory support","volume":"38","author":"Wieruszewski","year":"2023","journal-title":"J Intensive Care Med"},{"key":"10.1053\/j.jvca.2024.12.022_bib0030","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1177\/08850666231174870","article-title":"Trajectory of PaO2\/FiO2 ratio in shock after angiotensin II","volume":"38","author":"Wieruszewski","year":"2023","journal-title":"J Intensive Care Med"},{"key":"10.1053\/j.jvca.2024.12.022_bib0031","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1097\/CCM.0000000000005975","article-title":"Angiotensin II for the treatment of refractory shock: A matched analysis","volume":"51","author":"Smith","year":"2023","journal-title":"Crit Care Med"},{"key":"10.1053\/j.jvca.2024.12.022_bib0032","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1097\/SHK.0000000000002109","article-title":"A pilot study of angiotensin ii as primary vasopressor in critically ill adults with vasodilatory hypotension: The Aramis study","volume":"59","author":"See","year":"2023","journal-title":"Shock"},{"key":"10.1053\/j.jvca.2024.12.022_bib0033","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1177\/10600280231226132","article-title":"Clinical response to third-line angiotensin-II vs epinephrine in septic shock: A propensity-matched cohort study","volume":"58","author":"Blankenship","year":"2024","journal-title":"Ann Pharmacother"},{"key":"10.1053\/j.jvca.2024.12.022_bib0034","first-page":"e3665","article-title":"Angiotensin II use in refractory multisystem shock: A case report","volume":"10","author":"Ahmed","year":"2018","journal-title":"Cureus"},{"key":"10.1053\/j.jvca.2024.12.022_bib0035","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1213\/XAA.0000000000000775","article-title":"When all else fails: Novel use of angiotensin II for vasodilatory shock: A case report","volume":"11","author":"Chow","year":"2018","journal-title":"A A Pract"},{"key":"10.1053\/j.jvca.2024.12.022_bib0036","doi-asserted-by":"crossref","first-page":"e0036","DOI":"10.1097\/CCE.0000000000000036","article-title":"Synthetic human angiotensin II in pediatric patients with vasodilatory shock: A report on two patients","volume":"1","author":"Bailey","year":"2019","journal-title":"Crit Care Explor"},{"key":"10.1053\/j.jvca.2024.12.022_bib0037","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1016\/j.athoracsur.2018.11.047","article-title":"Use of angiotensin II for post cardiopulmonary bypass vasoplegic syndrome","volume":"108","author":"Evans","year":"2019","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2024.12.022_bib0038","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1053\/j.jvca.2019.03.004","article-title":"Synthetic human angiotensin II for postcardiopulmonary bypass vasoplegic shock","volume":"33","author":"Wieruszewski","year":"2019","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2024.12.022_bib0039","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1053\/j.jvca.2019.03.054","article-title":"Use of angiotensin II for vasoplegic shock in a combined heart and liver transplant recipient with systolic anterior motion physiology","volume":"33","author":"Wieruszewski","year":"2019","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2024.12.022_bib0040","doi-asserted-by":"crossref","first-page":"e01221","DOI":"10.1213\/XAA.0000000000001221","article-title":"Effective use of angiotensin II in coronavirus disease 19-associated mixed shock state: A case report","volume":"14","author":"Bobeck","year":"2020","journal-title":"A A Pract"},{"key":"10.1053\/j.jvca.2024.12.022_bib0041","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2019-233432","article-title":"Angiotensin II for the treatment of septic shock in a neutropenic patient with T-cell acute lymphoblastic leukaemia","volume":"13","author":"Bui","year":"2020","journal-title":"BMJ Case Rep"},{"key":"10.1053\/j.jvca.2024.12.022_bib0042","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.xjtc.2020.08.007","article-title":"Successful use of angiotensin II for vasoplegia after thoracoabdominal aortic aneurysm repair","volume":"4","author":"Chatterjee","year":"2020","journal-title":"JTCVS Tech"},{"key":"10.1053\/j.jvca.2024.12.022_bib0043","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1177\/1089253219877876","article-title":"Angiotensin II in decompensated cirrhosis complicated by septic shock","volume":"24","author":"Coleman","year":"2020","journal-title":"Semin Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2024.12.022_bib0044","doi-asserted-by":"crossref","first-page":"e01266","DOI":"10.1213\/XAA.0000000000001266","article-title":"Catecholamine-sparing effect of angiotensin II in an anephric patient with mixed shock after cardiac revascularization surgery: A case report","volume":"14","author":"Cutler","year":"2020","journal-title":"A A Pract"},{"key":"10.1053\/j.jvca.2024.12.022_bib0045","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/DCC.0000000000000414","article-title":"A patient with tricyclic antidepressant overdose with catecholamine-resistant hypotension rescued with angiotensin II: A case report","volume":"39","author":"Ferdowsali","year":"2020","journal-title":"Dimens Crit Care Nurs"},{"key":"10.1053\/j.jvca.2024.12.022_bib0046","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1186\/s13054-020-03143-7","article-title":"Angiotensin II treatment in COVID-19 patients: More risk than benefit? A single-center experience","volume":"24","author":"Heinicke","year":"2020","journal-title":"Crit Care"},{"key":"10.1053\/j.jvca.2024.12.022_bib0047","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1213\/XAA.0000000000001144","article-title":"Another role for angiotensin II? Vasopressin-refractory shock after pheochromocytoma resection: A case report","volume":"14","author":"Hylton","year":"2020","journal-title":"A A Pract"},{"key":"10.1053\/j.jvca.2024.12.022_bib0048","first-page":"388","article-title":"Feasibility and safety of angiotensin II administration in general ward patients during COVID-19 pandemic: A case series","volume":"22","author":"Morselli","year":"2020","journal-title":"Crit Care Resusc"},{"key":"10.1053\/j.jvca.2024.12.022_bib0049","doi-asserted-by":"crossref","first-page":"e912","DOI":"10.1097\/CCM.0000000000004502","article-title":"Use of angiotensin II in severe vasoplegia after left pneumonectomy requiring cardiopulmonary bypass: A renin response analysis","volume":"48","author":"Trethowan","year":"2020","journal-title":"Crit Care Med"},{"key":"10.1053\/j.jvca.2024.12.022_bib0050","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1016\/j.chest.2020.04.015","article-title":"Unexpected BP sensitivity to angiotensin II in a patient with coronavirus disease 2019, ARDS, and septic shock","volume":"158","author":"Wang","year":"2020","journal-title":"Chest"},{"key":"10.1053\/j.jvca.2024.12.022_bib0051","doi-asserted-by":"crossref","first-page":"e0185","DOI":"10.1097\/CCE.0000000000000185","article-title":"Vasopressor-refractory shock from clozapine overdose treated with synthetic angiotensin II infusion","volume":"2","author":"Wieruszewski","year":"2020","journal-title":"Crit Care Explor"},{"key":"10.1053\/j.jvca.2024.12.022_bib0052","article-title":"When all else fails: A rare case of postoperative toxic shock syndrome arising from surgical site infection after decompressive neurectomy successfully treated with angiotensin-2","volume":"2021","author":"Chandra","year":"2021","journal-title":"Case Rep Crit Care"},{"key":"10.1053\/j.jvca.2024.12.022_bib0053","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/1089253220949070","article-title":"Treatment of renin-angiotensin-aldosterone system dysfunction with angiotensin II in high-renin septic shock","volume":"25","author":"Chow","year":"2021","journal-title":"Semin Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2024.12.022_bib0054","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1053\/j.jvca.2020.07.087","article-title":"Angiotensin II for critically ill patients with shock after heart transplant","volume":"35","author":"Cutler","year":"2021","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2024.12.022_bib0055","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/HPC.0000000000000246","article-title":"Angiotensin II administration in patients with COVID-19 shock","volume":"20","author":"Ofosu-Barko","year":"2021","journal-title":"Crit Pathw Cardiol"},{"key":"10.1053\/j.jvca.2024.12.022_bib0056","doi-asserted-by":"crossref","first-page":"e01402","DOI":"10.1213\/XAA.0000000000001402","article-title":"Intraoperative use of angiotensin II for severe vasodilatory shock during liver transplantation: A case report","volume":"15","author":"Running","year":"2021","journal-title":"A A Pract"},{"key":"10.1053\/j.jvca.2024.12.022_bib0057","doi-asserted-by":"crossref","first-page":"e0434","DOI":"10.1097\/CCE.0000000000000434","article-title":"Angiotensin II for near drowning: A case series","volume":"3","author":"Smith","year":"2021","journal-title":"Crit Care Explore"},{"key":"10.1053\/j.jvca.2024.12.022_bib0058","doi-asserted-by":"crossref","first-page":"98","DOI":"10.14797\/mdcvj.576","article-title":"Angiotensin II: A multimodal approach to vasoplegia in a cardiac setting","volume":"17","author":"Sovic","year":"2021","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"10.1053\/j.jvca.2024.12.022_bib0059","doi-asserted-by":"crossref","first-page":"359","DOI":"10.4103\/aca.aca_98_21","article-title":"Outcomes following the use of angiotensin II in patients with postoperative vasoplegic syndrome: A case series","volume":"25","author":"Konkol","year":"2022","journal-title":"Ann Card Anaesth"},{"key":"10.1053\/j.jvca.2024.12.022_bib0060","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1053\/j.jvca.2022.01.002","article-title":"Angiotensin II in patients with shock on mechanical circulatory support: A single-center retrospective case series","volume":"36","author":"Mohamed","year":"2022","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2024.12.022_bib0061","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1177\/10600280221099928","article-title":"Evaluation of the addition of angiotensin II in patients with shock after cardiac surgery at a veterans affairs medical center","volume":"57","author":"Bird","year":"2023","journal-title":"Ann Pharmacother"},{"key":"10.1053\/j.jvca.2024.12.022_bib0062","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3325\/cmj.2023.64.201","article-title":"Intravenous infusion of angiotensin II for treatment of cardiopulmonary bypass-induced vasoplegic shock after implantation of left ventricular assist device: A case report","volume":"64","author":"\u0160ribar","year":"2023","journal-title":"Croat Med J"},{"key":"10.1053\/j.jvca.2024.12.022_bib0063","doi-asserted-by":"crossref","first-page":"e0978","DOI":"10.1097\/CCE.0000000000000978","article-title":"Utilization of synthetic human angiotensin II for catecholamine-resistant vasodilatory shock in critically ill children: A single-center retrospective case series","volume":"5","author":"Tezel","year":"2023","journal-title":"Crit Care Explor"},{"key":"10.1053\/j.jvca.2024.12.022_bib0064","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1177\/08971900221137389","article-title":"Angiotensin II use in treatment of refractory shock due to benazepril and amlodipine toxic ingestion","volume":"37","author":"Gutierrez","year":"2024","journal-title":"J Pharm Pract"},{"key":"10.1053\/j.jvca.2024.12.022_bib0065","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2023-062128","article-title":"Angiotensin-II use for refractory hypotension in an infant with bilateral renal agenesis","volume":"153","author":"Razdan","year":"2024","journal-title":"Pediatrics"},{"key":"10.1053\/j.jvca.2024.12.022_bib0066","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1186\/s13054-014-0534-9","article-title":"Intravenous angiotensin II for the treatment of high-output shock (ATHOS trial): A pilot study","volume":"18","author":"Chawla","year":"2014","journal-title":"Crit Care"},{"key":"10.1053\/j.jvca.2024.12.022_bib0067","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1172\/JCI105256","article-title":"Studies in clinical shock and hypotension. II. Hemodynamic effects of norepinephrine and angiotensin","volume":"44","author":"Cohn","year":"1965","journal-title":"J Clin Invest"},{"key":"10.1053\/j.jvca.2024.12.022_bib0068","first-page":"193","article-title":"The use of large doses of angiotensin in acute myocardial infarction with shock","volume":"85","author":"Belle","year":"1965","journal-title":"J Lancet"},{"key":"10.1053\/j.jvca.2024.12.022_bib0069","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/0140-6736(93)90479-Z","article-title":"Enalapril overdose treated with angiotensin infusion","volume":"341","author":"Jackson","year":"1993","journal-title":"Lancet"},{"key":"10.1053\/j.jvca.2024.12.022_bib0070","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1177\/106002809402801006","article-title":"Lisinopril overdose and management with intravenous angiotensin II","volume":"28","author":"Trilli","year":"1994","journal-title":"Ann Pharmacother"},{"key":"10.1053\/j.jvca.2024.12.022_bib0071","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1365-2125.1995.tb04546.x","article-title":"Enalapril overdose and the corrective effect of intravenous angiotensin II","volume":"40","author":"Newby","year":"1995","journal-title":"Br J Clin Pharmacol"},{"key":"10.1053\/j.jvca.2024.12.022_bib0072","first-page":"639","article-title":"Comparative study of angiotensin and nor-adrenaline in hypotensive states (shock)","volume":"14","author":"Singh","year":"1966","journal-title":"J Assoc Physicians India"},{"key":"10.1053\/j.jvca.2024.12.022_bib0073","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1136\/adc.82.5.388","article-title":"Angiotensin for septic shock unresponsive to noradrenaline","volume":"82","author":"Yunge","year":"2000","journal-title":"Arch Dis Child"},{"key":"10.1053\/j.jvca.2024.12.022_bib0074","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S1388-9842(01)00155-6","article-title":"Angiotensin in cardiac surgery: Efficacy in patients on angiotensin converting enzyme inhibitors","volume":"3","author":"Bennett","year":"2001","journal-title":"Eur J Heart Fail"},{"key":"10.1053\/j.jvca.2024.12.022_bib0075","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1177\/02676591231215920","article-title":"Angiotensin-II for vasoplegia following cardiac surgery","volume":"39","author":"Johnson","year":"2024","journal-title":"Perfusion"},{"key":"10.1053\/j.jvca.2024.12.022_bib0076","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.bja.2023.06.056","article-title":"Renin-angiotensin-aldosterone system dynamics after targeted blood pressure control using angiotensin II or norepinephrine in cardiac surgery: mechanistic randomised controlled trial","volume":"131","author":"Coulson","year":"2023","journal-title":"Br J Anaesth"},{"key":"10.1053\/j.jvca.2024.12.022_bib0077","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13054-024-04910-6","article-title":"ACE inhibitors and angiotensin receptor blockers differentially alter the response to angiotensin II treatment in vasodilatory shock","volume":"28","author":"Leisman","year":"2024","journal-title":"Crit Care"},{"key":"10.1053\/j.jvca.2024.12.022_bib0078","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1097\/CCM.0000000000006273","article-title":"Renin levels and angiotensin II responsiveness in vasopressor-dependent hypotension","volume":"52","author":"See","year":"2024","journal-title":"Crit Care Med"},{"key":"10.1053\/j.jvca.2024.12.022_bib0079","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.kint.2016.02.017","article-title":"Intrarenal and urinary oxygenation during norepinephrine resuscitation in ovine septic acute kidney injury","volume":"90","author":"Lankadeva","year":"2016","journal-title":"Kidney Int"},{"key":"10.1053\/j.jvca.2024.12.022_bib0080","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1007\/s00134-012-2487-2","article-title":"Renal bioenergetics during early gram-negative mammalian sepsis and angiotensin II infusion","volume":"38","author":"May","year":"2012","journal-title":"Intensive Care Med"},{"key":"10.1053\/j.jvca.2024.12.022_bib0081","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1161\/01.CIR.102.16.2011","article-title":"Pulmonary capillary endothelium-bound angiotensin-converting enzyme activity in acute lung injury","volume":"102","author":"Orfanos","year":"2000","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2024.12.022_bib0082","first-page":"1080","article-title":"Responses of serum and lung angiotensin-converting enzyme activities in the early phase of pulmonary damage induced by oleic acid in dogs","volume":"126","author":"Nukiwa","year":"1982","journal-title":"Am Rev Respir Dis"},{"key":"10.1053\/j.jvca.2024.12.022_bib0083","first-page":"H329","article-title":"Pulmonary vascular reactivity to biogenic amines during acute hypoxia","volume":"255","author":"Porcelli","year":"1988","journal-title":"Am J Physiol"},{"key":"10.1053\/j.jvca.2024.12.022_bib0084","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1378\/chest.71.2_Supplement.249","article-title":"Relation between hypoxic pulmonary vasoconstriction, its humoral mediators and alpha-beta adrenergic receptors","volume":"71","author":"Porcelli","year":"1977","journal-title":"Chest"},{"key":"10.1053\/j.jvca.2024.12.022_bib0085","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1152\/japplphysiol.00404.2012","article-title":"The effects of dobutamine and dopamine on intrapulmonary shunt and gas exchange in healthy humans","volume":"113","author":"Bryan","year":"2012","journal-title":"J Appl Physiol"},{"key":"10.1053\/j.jvca.2024.12.022_bib0086","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/SHK.0b013e318289376b","article-title":"Histologic pathologies of the myocardium in septic shock: A prospective observational study","volume":"39","author":"Schmittinger","year":"2013","journal-title":"Shock"},{"key":"10.1053\/j.jvca.2024.12.022_bib0087","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/s41569-020-00492-2","article-title":"Pathophysiology of sepsis-induced cardiomyopathy","volume":"18","author":"Hollenberg","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"10.1053\/j.jvca.2024.12.022_bib0088","unstructured":"U.S. Food and Drug Administration. FDA approves drug to treat dangerously low blood pressure. Available at:https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-drug-treat-dangerously-low-blood-pressure. 2020. Accessed November 14, 2024."},{"key":"10.1053\/j.jvca.2024.12.022_bib0089","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1097\/CCM.0000000000006433","article-title":"Angiotensin-II and thromboembolic events: A systematic review","volume":"52","author":"Caragata","year":"2024","journal-title":"Crit Care Med."},{"key":"10.1053\/j.jvca.2024.12.022_bib0090","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1097\/CCM.0000000000006468","article-title":"Angiotensin II and thromboembolism\u2014reading the fine print","volume":"52","author":"Kotani","year":"2024","journal-title":"Crit Care Med"},{"key":"10.1053\/j.jvca.2024.12.022_bib0091","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/MCC.0000000000001092","article-title":"The role of renin-angiotensin system in sepsis-associated acute kidney injury: Mechanisms and therapeutic implications","volume":"29","author":"Garcia","year":"2023","journal-title":"Curr Opin Crit Care"},{"key":"10.1053\/j.jvca.2024.12.022_bib0092","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1056\/NEJMoa2403769","article-title":"A randomized trial of intravenous amino acids for kidney protection","volume":"391","author":"Landoni","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2024.12.022_bib0093","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1001\/jama.2020.0930","article-title":"Effect of reduced exposure to vasopressors on 90-day mortality in older critically ill patients with vasodilatory hypotension: A randomized clinical trial","volume":"323","author":"Lamontagne","year":"2020","journal-title":"JAMA"},{"key":"10.1053\/j.jvca.2024.12.022_bib0094","series-title":"Cochrane Handbook for Systematic Reviews of Interventions version 6.5","article-title":"Chapter 24: Including non-randomized studies on intervention effects","author":"Reeves","year":"2019"},{"key":"10.1053\/j.jvca.2024.12.022_bib0095","article-title":"The latest consensus on angiotensin II: Still more work to be done","author":"Pospishil","year":"2024","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2024.12.022_bib0096","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1186\/s13054-024-05123-7","article-title":"The renin-angiotensin-aldosterone-system in sepsis and its clinical modulation with exogenous angiotensin II","volume":"28","author":"Legrand","year":"2024","journal-title":"Crit Care"},{"key":"10.1053\/j.jvca.2024.12.022_bib0097","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00134-023-07290-7","article-title":"Angiotensin II","volume":"50","author":"Bellomo","year":"2024","journal-title":"Intensive Care Med"},{"key":"10.1053\/j.jvca.2024.12.022_bib0098","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s44158-024-00150-w","article-title":"Angiotensin ii therapy in refractory septic shock: Which patient can benefit most? A narrative review","volume":"4","author":"Coloretti","year":"2024","journal-title":"J Anesth Analg Crit Care"},{"key":"10.1053\/j.jvca.2024.12.022_bib0099","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s44158-024-00186-y","article-title":"The use of angiotensin II for the management of distributive shock: expert consensus statements","volume":"4","author":"Landoni","year":"2024","journal-title":"J Anesth Analg Crit Care"},{"key":"10.1053\/j.jvca.2024.12.022_bib0100","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/CCM.0000000000003092","article-title":"Outcomes in patients with vasodilatory shock and renal replacement therapy treated with intravenous angiotensin II","volume":"46","author":"Tumlin","year":"2018","journal-title":"Crit Care Med"},{"key":"10.1053\/j.jvca.2024.12.022_bib0101","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s13613-023-01227-5","article-title":"Angiotensin II treatment is associated with improved oxygenation in ARDS patients with refractory vasodilatory shock","volume":"13","author":"Leisman","year":"2023","journal-title":"Ann Intensive Care"}],"container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077024009960?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077024009960?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T19:30:58Z","timestamp":1742239858000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053077024009960"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":101,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1053077024009960"],"URL":"https:\/\/doi.org\/10.1053\/j.jvca.2024.12.022","relation":{},"ISSN":["1053-0770"],"issn-type":[{"value":"1053-0770","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Efficacy and Safety of Angiotensin II for Treatment of Vasoplegia in Critically Ill Patients: A Systematic Review","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiothoracic and Vascular Anesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.jvca.2024.12.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}